A comparative study of histamine activities on differentiation of osteoblasts and osteoclasts

Journal of Toxicological Sciences

Volumn 32, Issue 5, 2007, Pages 555-564

  Ikawa, Yoshiko ^a   Yonekawa, Taeko ^a   Ohkuni, Yukie ^a   Kuribayashi, Mariko ^a   Fukino, Katsumi ^a   Ueno, Koichi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Histamine; Osteoblast differentiation; Osteoblast metabolism; Osteoclast differentiation; RANKL

Indexed keywords

CIMETIDINE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEPYRAMINE; MOLECULAR MARKER; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL TYPE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STEADY STATE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

EID: 38349003247     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.32.555     Document Type: Article

References (23)

1. Crisp, A.J., Wright, J.K. and Hazleman, B.L. (1986): Effects of heparin, histamine, and salmon calcitonin on mouse calvarial bone resorption. Ann. Rheum. Dis., 45, 422-427.
2. Deyama, Y., Kikuiri, T., Ohnishi, G., Feng, Y.G., Takeyama, S., Hatta, M., Yoshimura, Y. and Suzuki, K. (2002): Histamine stimulates production of osteoclast differentiation factor / receptor activator of nuclear factor-κB ligand by osteoblasts. Biochem. Biophys. Res. Commun., 298, 240-246.
3. 2 histamine receptors modulate osteoclastic resorption by different pathways: Evidence obtained by using receptor antagonists in a rat synchronized resorption model. J. Cell Physiol., 173, 10-18.
4. 2 Receptors. J. Immunol., 161, 2586-2593.
5. Fu, Q., Jilka, R.L., Manolagas, S.C. and O'Brien, C.A. (2002): Parathyroid Hormone Stimulates Receptor Activator of NFκB Ligand and Inhibits Osteoprotegerin Expression via Protein Kinase A Activation of cAMP-response Element-binding Protein. J. Biol. Chem., 277, 48868-48875.
6. Hall, T.J. and Schaueblin, M. (1994): Promethazine inhibits osteoclastic bone resorption In vitro. Calcif. Tissue Int., 55, 68-70.
7. Hill, S.J., Ganellin, C.R., Timmerman, H., Schwartz, J.C., Shankley, N.P., Young, J.M., Schunack, W., Levi, R. and Haas, H.L. (1997): International Union of Pharmacology. XIII. Classification of Histamine Receptors. Pharmacol. Rev., 49, 253-278.
8. Kanematsu, M., Yoshimura, K., Takaoki, M. and Sato, A. (2002): Vector-averaged gravity regulates gene expression of receptor activator of NF-κB (RANK) ligand and osteoprotegerin in bone marrow stromal cells via cyclic AMP/protein kinase A pathway. Bone, 30, 553-558.
9. 3 Augments Osteoclastogenesis via Vitamin D-Responsive Element of Mouse RANKL Gene Promoter. Biochem. Biophys. Res. Commun., 290, 650-655.
10. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R.T., Gao, Y.H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, S. and Kishimoto, T. (1997): Targeted Disruption of Cbfa1Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts. Cell, 89, 755-764.
11. Lee, S. K. and Lorenzo, J. A. (2002): Regulation of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures. Bone, 31, 252-259.
12. Nakamura, M., Kuroda, H., Narita, K. and Endo, Y. (1996): Parathyroid hormone induces a rapid increase in the number of active osteoclasts by releasing histamine from mast cells. Life Sci., 58, 1861-1868.
13. 2-receptor stimulation. Folia Pharmacol. Jpn., 118, 29-35.
14. 3 or Parathyroid Hormone. J. Biol. Chem., 274, 19301-19308.
15. 3 Receptors: Stimulation of IL-10 Production. J. Immunol., 164, 2964-2970.
16. Takami, M., Takahashi, N., Udagawa, N., Miyaura, C., Suda, K., Woo, J. T., Martin, T. J., Nagai, K. and Suda, T. (2000): Intracellular Calcium and Protein Kinase C Mediate Expression of Receptor Activator of Nuclear Factor-κB Ligand and Osteoprotegerin in Osteoblasts. Endocrinology, 141, 4711-4719.
17. Takayanagi, H. (2007): Osteoimmunology: Shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol., 7, 292-304.
18. Takeuchi, T., Tsuboi, T., Arai, M. and Togari, A. (2001): Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblastlike cells. Biochem. Pharmacol., 61, 579-586.
19. Tomita, M., Li, X., Okada, Y., Woodiel, F. N., Young, R.N., Pilbeam, C.C. and Raisz, L.G. (2002): Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro. Bone, 30, 159-163.
20. Wozney, J.M., Rosen, V., Celeste, A.J., Mitsock, L.M., Whitters, M.J., Kriz, R.W., Hewick, R.M. and Wang, E.A. (1998): Novel regulators of bone formation: Molecular clones and activities. Science, 242, 1528-1534.
21. Yamaguchi, A., Komori, T. and Suda, T. (2000): Regulation of Osteoblast Differentiation Mediated by Bone Morphogenetic Proteins, Hedgehogs, and Cbfa1. Endocr. Rev., 21, 393-411.
22. 2-Receptor Antagonist, Cimetidine, Inhibits the Articular Osteopenia in Rats With Adjuvant-Induced Arthritis by Suppressing the Osteoclast Differentiation Induced by Histamine. J. Pharmacol. Sci., 92, 43-49.
23. Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Goto, M., Mochizuki, S.I., Tsuda, E., Morinaga, T., Udagawa, N., Takahashi, N., Suda, T. and Higashio, K. (1999): A novel molecular mechanism modulating osteoclast differentiation and function. Bone, 25, 109-113.